Skip to main content
Log in

Mitigating algorithmic bias in opioid risk-score modeling to ensure equitable access to pain relief

  • Correspondence
  • Published:

From Nature Medicine

View current issue Submit your manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Acknowledgements

We thank J.M. Sharfstein for reviewing and providing feedback on this manuscript. We also thank R. Gibbons for helpful discussions on evidence-based screening tools, and M. Vogel for insight on ethics surrounding artificial intelligence and algorithms in healthcare. The views, opinions, and findings in this article are those of the authors. This project was funded through a grant from Bloomberg Philanthropies. The funding organization had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jason B. Gibbons.

Ethics declarations

Competing interests

K.S.F. is a member of the digital ethics advisory board for Merck and of the institutional review board for the US National Institutes of Health’s All of Us Research Program. The other authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bhagwat, A.M., Ferryman, K.S. & Gibbons, J.B. Mitigating algorithmic bias in opioid risk-score modeling to ensure equitable access to pain relief. Nat Med 29, 769–770 (2023). https://doi.org/10.1038/s41591-023-02256-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41591-023-02256-0

  • Springer Nature America, Inc.

Navigation